NAPRT Silencing in FH-Deficient Renal Cell Carcinoma Confers Therapeutic Vulnerabilities via NAD+ Depletion

Katelyn J. Noronha(Yale University), Ranjit S. Bindra(Yale University)
Molecular Cancer Research
July 1, 2024
10.1158/1541-7786.mcr-23-1003
Cited by 5

Related Papers

Mismatch repair proteins play a role in ATR activation upon temozolomide treatment in MGMT-methylated glioblastoma
|Scientific Reports|2022|23
Exploiting Metabolic Defects in Glioma with Nanoparticle-Encapsulated NAMPT Inhibitors
|Molecular Cancer Therapeutics|2024|6
PARG inhibition induces nuclear aggregation of PARylated PARP1
|bioRxiv (Cold Spring Harbor Laboratory)|2023|0